Synthetic phosphoantigens enhance human Vgamma9Vdelta2 T lymphocytes killing of non-Hodgkin's B lymphoma.

BACKGROUND: Non-Hodgkin's B lymphomas (NHL) are often resistant to conventional treatments and, until now, immunotherapeutic approaches against NHL only aimed at inducing anti-tumor effectors. Nevertheless, human blood Vgamma9Vdelta2 T lymphocytes represent an abundant pool of cytotoxic tumor-r...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Sicard, H., Al Saati, T., Delsol, G., Fournié, J. J.
Format: Artigo
Jezik:Inglês
Izdano: 2001
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1950000/
https://ncbi.nlm.nih.gov/pubmed/11713370
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items